Functional promoter variant rs2868371 of HSPB1 is associated with risk of radiation pneumonitis after chemoradiation for non-small cell lung cancer.

PURPOSE To date, no biomarkers have been found to predict, before treatment, which patients will develop radiation pneumonitis (RP), a potentially fatal toxicity, after chemoradiation for lung cancer. We investigated potential associations between single nucleotide polymorphisms (SNPs) in HSPB1 and risk of RP after chemoradiation for non-small cell lung cancer (NSCLC). METHODS AND MATERIALS Subjects were patients with NSCLC treated with chemoradiation at 1 institution. The training data set comprised 146 patients treated from 1999 to July 2004; the validation data set was 125 patients treated from August 2004 to March 2010. We genotyped 2 functional SNPs of HSPB1 (rs2868370 and rs2868371) from all patients. We used Kaplan-Meier analysis to assess the risk of grade ≥2 or ≥3 RP in both data sets and a parametric log-logistic survival model to evaluate the association of HSPB1 genotypes with that risk. RESULTS Grade ≥3 RP was experienced by 13% of those with CG/GG and 29% of those with CC genotype of HSPB1 rs2868371 in the training data set (P=.028); corresponding rates in the validation data set were 2% CG/GG and 14% CC (P=.02). Univariate and multivariate analysis confirmed the association of CC of HSPB1 rs2868371 with higher risk of grade ≥3 RP than CG/GG after adjustment for sex, age, performance status, and lung mean dose. This association was validated both in the validation data set and with Harrell's C statistic. CONCLUSIONS The CC genotype of HSPB1 rs2868371 was associated with severe RP after chemoradiation for NSCLC.

[1]  Q. Wei,et al.  Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non‐small cell lung cancer patients treated with definitive radiotherapy , 2012, Cancer science.

[2]  Hongbing Shen,et al.  Functional promoter -1271G>C variant of HSPB1 predicts lung cancer risk and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  B. Wilson,et al.  Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. , 2007, Neoplasia.

[4]  R. Clough,et al.  Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. , 2001, International journal of radiation oncology, biology, physics.

[5]  A. Arrigo.  Review Article Hsp27: Novel Regulator of Intracellular Redox State , 2001 .

[6]  R. Wu,et al.  Differential expression of stress proteins in nonhuman primate lung and conducting airway after ozone exposure. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[7]  R. Morimoto,et al.  Molecular chaperones and the stress of oncogenesis , 2004, Oncogene.

[8]  Radhe Mohan,et al.  Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. , 2013, International journal of radiation oncology, biology, physics.

[9]  D. Xue,et al.  Regulation of mitochondrial membrane permeabilization by BCL-2 family proteins and caspases. , 2004, Current opinion in cell biology.

[10]  E. Gerner,et al.  Induced thermal resistance in HeLa cells , 1975, Nature.

[11]  R. Mohan,et al.  Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[13]  R. Cowan,et al.  A potential role of heat shock proteins and nicotinamide N‐methyl transferase in predicting response to radiation in bladder cancer , 2002, International journal of cancer.

[14]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[15]  Q. Wei,et al.  Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Radhe Mohan,et al.  Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[17]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[18]  Radhe Mohan,et al.  Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[19]  G. Hunninghake,et al.  Idiopathic pulmonary fibrosis. , 2001, The New England journal of medicine.

[20]  P. García-Barreno,et al.  Peripheral leukocyte response to oncological radiotherapy: Expression of heat shock proteins , 2006, International journal of radiation biology.

[21]  Zhongxing Liao,et al.  Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). , 2005, International journal of radiation oncology, biology, physics.

[22]  M. Martel,et al.  Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  K. Fung,et al.  Murine Cells Transfected with Human Hsp27 cDNA Resist TNF‐Induced Cytotoxicity , 1996, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[24]  Jacques Landry,et al.  Inhibition of Daxx-Mediated Apoptosis by Heat Shock Protein 27 , 2000, Molecular and Cellular Biology.

[25]  Hae-June Lee,et al.  Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide. , 2007, Cancer research.

[26]  M. Dewhirst,et al.  Predicting lung radiotherapy-induced pneumonitis using a model combining parametric Lyman probit with nonparametric decision trees. , 2007, International journal of radiation oncology, biology, physics.

[27]  B. Chauffert,et al.  HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. , 1997, Cancer research.

[28]  Q. Wei,et al.  Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy , 2012, Cancer.

[29]  H. Cha,et al.  Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells , 2007, FEBS letters.

[30]  R. Mohan,et al.  HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[31]  Hubert Thierens,et al.  Predicting risk of radiation-induced lung injury. , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[32]  J. Bousquet,et al.  Heat shock protein-27 protects human bronchial epithelial cells against oxidative stress–mediated apoptosis: possible implication in asthma , 2002, Cell stress & chaperones.

[33]  M. Koukourakis,et al.  Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. , 2006, International journal of radiation oncology, biology, physics.